Back

The clinical value of estimated small dense LDL in primary and secondary prevention

29 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Clinico-metabolic phenotyping and heart disease (2) Biomarkers ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Dimitrios Delialis

Alexandra University Hospital, Athens (Greece)

5 More presentations in this session

Presentation thumbnail
Clinico-metabolic phenotyping predicts long-term mortality in at-risk and pre-clinical heart failure: a machine learning analysis
Miss A. Mavromanoli (Mainz, DE)
Abstract Slides Video
Presentation thumbnail
Understanding and predicting CVD in Singapore: socioeconomic determinants and a non-lab risk score across two cohorts
Professor D. Hausenloy (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prediction and cumulative incidence of in-hospital bleeding among acutely ill medical patients receiving pharmacologic VTE prophylaxis based on the IMPROVE-BRS: a retrospective single-center cohort
Doctor J. Catangui (Manila, PH)
Abstract Slides Video
Presentation thumbnail
Primary care detection reveals substantial cumulative LDL-C exposure in underrecognized heterozygous FH
Doctor H. Leskaroska (Skopje, MK)
Abstract Slides Video
Presentation thumbnail
Development and external validation of a clinical model to estimate symptom-limited cardiopulmonary exercise testing parameters for prognostication in heart failure
Doctor C. Wang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Clinico-metabolic phenotyping and heart disease (2)

The Event

Event poster

ESC Congress 2026

29 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Small dense LDL, clinical characteristics and survival - an analysis of LIPIDOGRAM2004-2015 cohort studies
30 August 2026
thumbnail
Congress Presentation
Radiomics and artificial intelligence for coronary calcium scoring: insights from the CAC CV-PREVITAL study
28 August 2026
thumbnail
Congress Presentation
Utilizing existing test results to improve primary prevention in patients with subclinical coronary atherosclerosis: the USE-IT study
30 August 2025
thumbnail
Congress Presentation
Icosapent ethyl by baseline small dense low-density lipoprotein cholesterol: an analysis of REDUCE-IT
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources